Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tetanus, diphtheria and pertussis vaccination and risk for incident dementia among adults with down syndrome.

The journal of prevention of Alzheimer's disease·2026
Same author

[Inspection and workplace fatalities: between expectations and reality].

Epidemiologia e prevenzione·2026
Same author

The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults.

Vaccine·2026
Same author

The impact of B-cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipients.

Clinical & translational immunology·2026
Same author

Controlled human infection with Mycobacterium tuberculosis: practical considerations for clinical trials.

The Lancet. Microbe·2026
Same author

Oral Microbiome Diversity Matters on Nucleos(t)ide Analogue Cessation in Chronic Hepatitis B.

The Journal of infectious diseases·2025

Related Experiment Video

Updated: Jun 27, 2026

Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

Pattern recognition in pulmonary tuberculosis defined by high content peptide microarray chip analysis representing

Simani Gaseitsiwe1, Davide Valentini, Shahnaz Mahdavifar

  • 1Department of Microbiology, Tumor and Cell Biology Center (MTC), Karolinska Institutet Stockholm, Stockholm, Sweden.

Plos One
|December 10, 2008
PubMed
Summary

Researchers identified a consistent Mycobacterium tuberculosis (MTB) IgG-epitope recognition pattern in tuberculosis patients. This discovery using peptide microarrays can aid in developing new diagnostics and vaccines for tuberculosis (TB).

More Related Videos

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Related Experiment Videos

Last Updated: Jun 27, 2026

Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis
08:48

Separation and Fractionation of Culture Filtrate Proteins (CFPs) from Mycobacterium tuberculosis

Published on: July 11, 2025

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Area of Science:

  • Immunology
  • Infectious Diseases
  • Biotechnology

Background:

  • Serum antibody profiling is a method for identifying tumor-associated antigens (TAAs) for anti-cancer vaccine development.
  • A similar approach can identify targets for diagnosing or developing vaccines against Mycobacterium tuberculosis (MTB).

Purpose of the Study:

  • To identify biologically relevant and clinically meaningful targets in Mycobacterium tuberculosis (MTB) infection.
  • To develop novel diagnostics and vaccines for tuberculosis (TB).

Main Methods:

  • Constructed a high-content peptide microarray with 61 MTB proteins, creating 7446 unique peptide epitopes.
  • Performed antibody profiling using serum from 34 active pulmonary TB patients and 35 healthy individuals.
  • Analyzed data for significant differences and patterns predictive of TB status.

Main Results:

  • Identified three distinct IgG reactivity patterns: differentially recognized peptides, peptides exclusively recognized in TB+ patients, and peptides exclusively recognized in healthy individuals.
  • Found that TB+ and TB- segregation was based on specific peptide epitope 'hotspots' within proteins, not distinct proteins.
  • Observed highly similar IgG-defined MTB epitope recognition patterns across patients with different genetic backgrounds.

Conclusions:

  • A uniform target MTB IgG-epitope recognition pattern exists in pulmonary tuberculosis.
  • High-content peptide microarray testing of well-defined populations can reveal biologically relevant targets.
  • These targets are useful for developing novel TB diagnostics and vaccines.